STOCK TITAN
  1. Home
  2. Sec-filings
  3. CING
  4. [EFFECT] Cingulate Inc. SEC Filing

[EFFECT] Cingulate Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 24, 2026 4:30 P.M.
Form: S-3
CIK: 0001862150
Company Name: Cingulate Inc.
File Number: 333-292680

Source: View Original Filing on SEC EDGAR

Cingulate Inc

NASDAQ:CING

View CING Stock Overview →

CING Rankings

#5241 Ranked by Market Cap
N/A Ranked by Dividends
#184 Top Loser

CING Latest News

Mar 18, 2026
Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Feb 17, 2026
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Nov 18, 2025
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 3Q25
Nov 13, 2025
Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 10, 2025
Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation for CTx-1301

CING Latest SEC Filings

Mar 24, 2026
[424B3] Cingulate Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Mar 24, 2026
[8-K] Cingulate Inc. Reports Material Event
Mar 23, 2026
[S-3/A] Cingulate Inc. Amended Shelf Registration Statement
Mar 20, 2026
[S-3] Cingulate Inc. Shelf Registration Statement
Mar 18, 2026
[8-K] Cingulate Inc. Reports Material Event

CING Stock Data

80.59M
9.30M
Biotechnology
Pharmaceutical Preparations
Link
United States
KANSAS CITY